GPC3 and hepatocellular carcinoma: Significant anti-tumor activities of GPC3-CAR-NK-92 cells against hepatocellular carcinoma xenografts with both high and low GPC3 expression, as showed by reduced tumor proliferation, and boosted tumor apoptosis